Doctor Malgorzata Chlabicz

Doctor Malgorzata Chlabicz

Medical University of Bialystok, Bialystok (Poland)

Dr Malgorzata Chlabicz is a cardiologist in Department of Invasive Cardiology, Teaching University Hospital, Bialystok, Poland. She completed training in cardiology and specializes in cardiac pacing and implantable cardioverter defibrillators, certified EHRA CP in 2017. She is also academic teacher in the Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, Bialystok, Poland.

Presentations

Association of right and left atrial strain with laboratory, anthropometric and echocardiographic markers - the influence of COVID-19 pandemic

Event: ESC Preventive Cardiology 2023

Topic: Echocardiography, Other

Session: Moderated ePoster 21

Access

Enlarged dimensions of cardiac chambers and the root of the aorta as a significant cardiovascular impact of pandemic COVID-19: a population-based study

Event: ESC Preventive Cardiology 2023

Topic: Echocardiography, Other

Session: ePosters

Access

Very similar cardiometabolic profile in the moderate and high cardiovascular risk classes: a population-based study

Event: ESC Preventive Cardiology 2021

Topic: Scores

Session: ePosters

Access

The impact of legs fat mass and legs lean fat mass on thigh circumference according cardiovascular risk: a population-based study

Event: ESC Preventive Cardiology 2021

Topic: Cardiovascular Risk Assessment, Other

Session: ePosters

Access

Clinical variables improve efficacy of ECG scores to diagnose the left ventricular hypertrophy in general population

Event: ESC Congress 2020

Topic: Scores

Session: Risk Factors and Prevention ePosters

Access

Value of N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hs-c TnT) as markers of left ventricular hypertrophy in the potentially healthy populations

Event: EuroPrevent 2019

Topic: Biomarkers

Session: Risk Factors and Prevention – Cardiovascular Risk Assessment

Access

Doctor Malgorzata Chlabicz

Biography

Contributor content

Association of right and left atrial strain with laboratory, anthropometric and echocardiographic markers - the influence of COVID-19 pandemic

Enlarged dimensions of cardiac chambers and the root of the aorta as a significant cardiovascular impact of pandemic COVID-19: a population-based study

Very similar cardiometabolic profile in the moderate and high cardiovascular risk classes: a population-based study

The impact of legs fat mass and legs lean fat mass on thigh circumference according cardiovascular risk: a population-based study

Clinical variables improve efficacy of ECG scores to diagnose the left ventricular hypertrophy in general population

Value of N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hs-c TnT) as markers of left ventricular hypertrophy in the potentially healthy populations

ESC 365 is supported by